Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
$0.40
-2.2%
$0.34
$0.14
$1.31
$16.88M1.923.74 million shs579,868 shs
ENFY
Enlightify
$1.01
-8.2%
$1.05
$0.70
$2.72
$17.34M0.9330,765 shs4.26 million shs
Evogene Ltd. stock logo
EVGN
Evogene
$1.33
+6.4%
$1.32
$0.95
$6.30
$6.71M1.58629,808 shs90,215 shs
TOMI Environmental Solutions, Inc. stock logo
TOMZ
TOMI Environmental Solutions
$0.96
+0.1%
$0.99
$0.60
$1.50
$19.22M1.1171,976 shs8,947 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
-1.44%+1.51%-5.98%+110.42%-68.92%
ENFY
Enlightify
-2.66%-0.02%+2.79%-2.72%+109,979,900.00%
Evogene Ltd. stock logo
EVGN
Evogene
-0.79%-16.11%-17.76%+28.87%-80.47%
TOMI Environmental Solutions, Inc. stock logo
TOMZ
TOMI Environmental Solutions
+2.14%-4.45%-11.09%+26.51%+20.03%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
3.0509 of 5 stars
3.25.00.00.03.30.80.6
ENFY
Enlightify
N/AN/AN/AN/AN/AN/AN/AN/A
Evogene Ltd. stock logo
EVGN
Evogene
2.9011 of 5 stars
3.55.00.00.02.70.00.6
TOMI Environmental Solutions, Inc. stock logo
TOMZ
TOMI Environmental Solutions
3.354 of 5 stars
3.55.00.00.02.81.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
2.43
Hold$1.93386.97% Upside
ENFY
Enlightify
0.00
N/AN/AN/A
Evogene Ltd. stock logo
EVGN
Evogene
3.00
Buy$3.50163.16% Upside
TOMI Environmental Solutions, Inc. stock logo
TOMZ
TOMI Environmental Solutions
3.00
Buy$3.50264.20% Upside

Current Analyst Ratings Breakdown

Latest EVGN, CARM, TOMZ, and ENFY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/22/2025
Evogene Ltd. stock logo
EVGN
Evogene
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$5.00 ➝ $3.50
(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
$19.63M0.84N/AN/A($0.67) per share-0.59
ENFY
Enlightify
$95.85M0.17N/AN/A$6.77 per share0.15
Evogene Ltd. stock logo
EVGN
Evogene
$8.51M0.84N/AN/A$2.77 per share0.48
TOMI Environmental Solutions, Inc. stock logo
TOMZ
TOMI Environmental Solutions
$7.74M2.48N/AN/A$0.20 per share4.81
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
-$60.48M-$1.56N/AN/AN/A-254.28%N/A-137.38%8/6/2025 (Estimated)
ENFY
Enlightify
-$28.41M-$1.25N/AN/A-22.98%-18.78%-11.03%N/A
Evogene Ltd. stock logo
EVGN
Evogene
-$16.49M-$2.69N/AN/A-224.82%-102.40%-39.19%8/28/2025 (Estimated)
TOMI Environmental Solutions, Inc. stock logo
TOMZ
TOMI Environmental Solutions
-$4.48M-$0.17N/A48.05N/A-43.18%-22.42%-11.32%7/30/2025 (Estimated)

Latest EVGN, CARM, TOMZ, and ENFY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
TOMI Environmental Solutions, Inc. stock logo
TOMZ
TOMI Environmental Solutions
-$0.03N/AN/AN/AN/AN/A
7/10/2025Q1 2025
ENFY
Enlightify
N/A-$0.06N/A-$0.06N/A$24.79 million
5/21/2025Q1 2025
Evogene Ltd. stock logo
EVGN
Evogene
-$0.50-$0.38+$0.12-$0.38$4.42 million$2.44 million
5/13/2025Q1 2025
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
-$0.17-$0.22-$0.05-$0.22$2.47 million$3.65 million
5/8/2025Q4 2024
TOMI Environmental Solutions, Inc. stock logo
TOMZ
TOMI Environmental Solutions
-$0.05-$0.01+$0.04-$0.01$3.45 million$1.58 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
N/AN/AN/AN/AN/A
ENFY
Enlightify
N/AN/AN/AN/AN/A
Evogene Ltd. stock logo
EVGN
Evogene
N/AN/AN/AN/AN/A
TOMI Environmental Solutions, Inc. stock logo
TOMZ
TOMI Environmental Solutions
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
N/A
1.34
1.34
ENFY
Enlightify
0.08
1.95
1.44
Evogene Ltd. stock logo
EVGN
Evogene
N/A
1.06
0.92
TOMI Environmental Solutions, Inc. stock logo
TOMZ
TOMI Environmental Solutions
0.68
2.25
1.12

Institutional Ownership

CompanyInstitutional Ownership
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
44.27%
ENFY
Enlightify
0.12%
Evogene Ltd. stock logo
EVGN
Evogene
10.40%
TOMI Environmental Solutions, Inc. stock logo
TOMZ
TOMI Environmental Solutions
4.77%

Insider Ownership

CompanyInsider Ownership
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
6.90%
ENFY
Enlightify
13.96%
Evogene Ltd. stock logo
EVGN
Evogene
7.40%
TOMI Environmental Solutions, Inc. stock logo
TOMZ
TOMI Environmental Solutions
23.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
2041.79 million38.91 millionNo Data
ENFY
Enlightify
42415.77 million13.57 millionN/A
Evogene Ltd. stock logo
EVGN
Evogene
1405.37 million4.97 millionOptionable
TOMI Environmental Solutions, Inc. stock logo
TOMZ
TOMI Environmental Solutions
2020.01 million15.23 millionNot Optionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Carisma Therapeutics stock logo

Carisma Therapeutics NASDAQ:CARM

$0.40 -0.01 (-2.15%)
Closing price 04:00 PM Eastern
Extended Trading
$0.40 +0.01 (+1.44%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Carisma Therapeutics, Inc., a clinical-stage cell therapy company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases in the United States. The company's ex vivo CAR-M cell therapies include CT-0508, a CAR-macrophage, which is in Phase 1 clinical trial to treat solid tumors; CT-0525, a CAR-monocyte that is in Phase 1 clinical trial to treat solid tumors; and CT-1119, a mesothelin-targeted CAR-Monocyte that is in pre-clinical stage to treat patients with advanced mesothelin-positive solid tumors, including lung cancer, mesothelioma, pancreatic cancer, ovarian cancer, and others. It is also developing in vivo CAR-M cell therapies in collaboration with Moderna Therapeutics to address multiple cancer targets; and multiple assets for the potential treatment of diseases beyond oncology, including fibrosis and other immunologic and inflammatory diseases. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. The company was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.

Enlightify NYSE:ENFY

$1.01 -0.09 (-8.17%)
As of 03:59 PM Eastern

Enlightify, Inc. engages in the research, development, production, and sale of various types of fertilizers and agricultural products. It operates through the following segments: Jinong, Gufeng, and Yuxing. The Jinong segment includes fertilizer products, with focus on humic acid-based compound fertilizer. The Gufeng segment refers to the compound fertilizer, blended fertilizer, organic compound fertilizer, slow-release fertilizers, highly concentrated water-soluble fertilizers, and mixed organic-inorganic compound fertilizer. The Yuxing segment develops and produces agricultural products, such as top-grade fruits, vegetables, flowers, and colored seedlings. The company was founded by Tao Li on February 6, 1987 and is headquartered in Xi'an, China.

Evogene stock logo

Evogene NASDAQ:EVGN

$1.33 +0.08 (+6.40%)
Closing price 03:58 PM Eastern
Extended Trading
$1.34 +0.01 (+1.13%)
As of 07:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.

TOMI Environmental Solutions stock logo

TOMI Environmental Solutions NASDAQ:TOMZ

$0.98 +0.02 (+2.58%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

TOMI Environmental Solutions, Inc., a bacteria decontamination and infectious disease control company, engages in the provision of environmental solutions for indoor air and surface disinfection and decontamination in the United States and internationally. The company's disinfection solutions include SteraPak portable disinfection systems, SteraMist select surface units, SteraMist environment systems, SteraMist total disinfection carts, SteraMist transport units, NV+ fogging disinfection and decontamination systems, SteraMist custom engineered systems, SteraMist Hybrid disinfection systems, SteraMist integrated systems, Stainless Steel 90-Degree applicators, SteraMist plasma decontamination chambers, and iHP Corporate Service Decontamination, which provides full room, equipment, facility, and emergency disinfection and decontamination services. It also manufactures, sells, services, and licenses SteraMist Binary Ionization Technology, a hydrogen peroxide-based mist and fog. The company's products and services are used in hospitals and medical facilities, bio-safety labs, pharmaceutical facilities, meat and produce processing facilities, universities and research facilities, vivarium labs, and other service industries, including cruise ships, office buildings, hotel and motel rooms, schools, restaurants, military barracks, police and fire departments, prisons, and athletic facilities; and single-family homes and multi-unit residences. TOMI Environmental Solutions, Inc. was incorporated in 1979 and is headquartered in Frederick, Maryland.